Will Biogen Beat Estimates Again in Its Next Earnings Report?

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Biogen Inc. (NASDAQ: BIIB). This company, which is in the Zacks Medical – Biomedical and Genetics industry, shows potential for another earnings beat.

This company has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. The average surprise for the last two quarters was 19.19%.

For the last reported quarter, Biogen came out with earnings of $5.28 per share versus the Zacks Consensus Estimate of $4 per share, representing a surprise of 32%. For the previous quarter, the company was expected to post earnings of $3.45 per share and it actually produced earnings of $3.67 per share, delivering a …

Full story available on Benzinga.com